Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/13412
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSrikuea R.
dc.contributor.authorHirunsai M.
dc.date.accessioned2021-04-05T03:23:49Z-
dc.date.available2021-04-05T03:23:49Z-
dc.date.issued2016
dc.identifier.issn87507587
dc.identifier.other2-s2.0-84983604708
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/13412-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84983604708&doi=10.1152%2fjapplphysiol.01018.2015&partnerID=40&md5=27c8b6eca6a56731ea580b4353f1b2f2
dc.description.abstractThe recent discovery of the vitaminDreceptor (VDR) in regenerating muscle raises the question regarding the action of Vitamin D3 on skeletal muscle regeneration. To investigate the action of Vitamin D3 on this process, the tibialis anterior muscle of male C57BL/6 mice (10 wk of age) was injected with 1.2% BaCl2 to induce extensive muscle injury. The bioactive form of Vitamin D3 [1α,25(OH)2D3] was administered daily via intramuscular injections during the regenerative phase (days 4-7 postinjury). Physiological and supraphysiological doses of 1α,25(OH)2D3 relative to 1 αg/kg muscle wet weight and mouse body weight were investigated. Muscle samples were collected on day 8 postinjury to examine proteins related to Vitamin D3 metabolism (VDR, CYP24A1, and CYP27B1), satellite cell differentiation and regenerative muscle fiber formation [myogenin and embryonic myosin heavy chain (EbMHC)], protein synthesis signaling (Akt, p70 S6K1, 4E-BP1, and myostatin), fiber-Type composition (fast and slow MHCs), fibrous formation (vimentin), and angiogenesis (CD31). Administration of 1α,25(OH)2D3 at physiological and supraphysiological doses enhanced VDR expression in regenerative muscle. Moreover, CYP24A1 and vimentin expression was increased, accompanying decreased myogenin and EbMHC expression at the supraphysiological dose. However, there was no change in CYP27B1, Akt, p70 S6K1, 4E-BP1, myostatin, fast and slow MHCs, or CD31 expression at any dose investigated. Taken together, administration of 1α,25(OH)2D3 at a supraphysiological dose decreased satellite cell differentiation, delayed regenerative muscle fiber formation, and increased muscular fibrosis. However, protein synthesis signaling, fiber-Type composition, and angiogenesis were not affected by either 1α,25(OH)2D3 administration at a physiological or supraphysiological dose. © 2016 the American Physiological Society.
dc.subjectcalcitriol receptor
dc.subjectcolecalciferol
dc.subjectmyogenin
dc.subjectmyosin heavy chain
dc.subjectanimal
dc.subjectC57BL mouse
dc.subjectcell differentiation
dc.subjectdrug effects
dc.subjectfibrosis
dc.subjectintramuscular drug administration
dc.subjectmale
dc.subjectmetabolism
dc.subjectmorphogenesis
dc.subjectmouse
dc.subjectmuscle disease
dc.subjectneovascularization (pathology)
dc.subjectprocedures
dc.subjectregeneration
dc.subjectskeletal muscle
dc.subjectwound healing
dc.subjectAnimals
dc.subjectCell Differentiation
dc.subjectCholecalciferol
dc.subjectFibrosis
dc.subjectInjections, Intramuscular
dc.subjectMale
dc.subjectMice
dc.subjectMice, Inbred C57BL
dc.subjectMorphogenesis
dc.subjectMuscle, Skeletal
dc.subjectMuscular Diseases
dc.subjectMyogenin
dc.subjectMyosin Heavy Chains
dc.subjectNeovascularization, Pathologic
dc.subjectReceptors, Calcitriol
dc.subjectRegeneration
dc.subjectWound Healing
dc.titleEffects of intramuscular administration of 1α,25(OH)2D3 during skeletal muscle regeneration on regenerative capacity, muscular fibrosis, and angiogenesis
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of Applied Physiology. Vol 120, No.12 (2016), p.1381-1393
dc.identifier.doi10.1152/japplphysiol.01018.2015
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.